Asymchem Laboratories (Tianjin) Co., Ltd. (SHE:002821)
China · Delayed Price · Currency is CNY 139.66
-12.58 (-8.26%)
Oct 22, 2026, 3:04 PM CST
SHE:002821 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 21, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 49,176 | 32,605 | 26,238 | 41,387 | 52,704 | 111,228 | |
Market Cap Growth | 30.10% | 24.27% | -36.60% | -21.47% | -52.62% | 53.32% |
Enterprise Value | 43,224 | 25,052 | 19,216 | 32,347 | 45,076 | 109,745 |
Last Close Price | 139.66 | 92.13 | 74.47 | 110.60 | 138.96 | 290.86 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 21, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 41.73 | 28.79 | 27.65 | 18.24 | 15.97 | 104.12 |
Forward PE | 30.00 | 25.63 | 19.91 | 17.92 | 19.50 | 77.49 |
PS Ratio | 6.61 | 4.89 | 4.52 | 5.29 | 5.15 | 24.01 |
PB Ratio | 2.76 | 1.85 | 1.56 | 2.36 | 3.36 | 8.82 |
P/TBV Ratio | 2.86 | 1.91 | 1.61 | 2.45 | 3.41 | 8.97 |
P/FCF Ratio | - | 237.61 | 211.04 | 17.93 | 46.38 | - |
P/OCF Ratio | 56.61 | 23.16 | 20.92 | 11.66 | 16.03 | 983.02 |
PEG Ratio | 1.47 | 1.50 | 11.27 | 2.24 | 0.70 | 2.28 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 21, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 5.81 | 3.76 | 3.31 | 4.13 | 4.41 | 23.69 |
EV/EBITDA Ratio | 21.16 | 16.09 | 17.87 | 12.22 | 13.13 | 88.31 |
EV/EBIT Ratio | 31.76 | 23.46 | 31.06 | 14.57 | 14.49 | 104.97 |
EV/FCF Ratio | - | 182.56 | 154.55 | 14.02 | 39.67 | - |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 21, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.04 | 0.02 | 0.02 | 0.01 | 0.01 | 0.03 |
Debt / EBITDA Ratio | 0.36 | 0.19 | 0.29 | 0.05 | 0.04 | 0.35 |
Debt / FCF Ratio | - | 2.25 | 2.61 | 0.06 | 0.12 | - |
Net Debt / Equity Ratio | -0.33 | -0.42 | -0.43 | -0.51 | -0.46 | -0.49 |
Net Debt / EBITDA Ratio | -3.23 | -4.72 | -6.75 | -3.35 | -2.13 | -4.99 |
Net Debt / FCF Ratio | 6.13 | -53.50 | -58.38 | -3.84 | -6.43 | 4.01 |
Asset Turnover | 0.36 | 0.34 | 0.30 | 0.41 | 0.61 | 0.42 |
Inventory Turnover | 2.24 | 2.95 | 3.17 | 3.12 | 3.71 | 2.43 |
Quick Ratio | 3.40 | 5.01 | 5.69 | 6.26 | 4.58 | 3.84 |
Current Ratio | 4.50 | 5.85 | 6.47 | 6.86 | 5.45 | 4.68 |
Return on Equity (ROE) | 6.69% | 6.53% | 5.45% | 13.56% | 23.28% | 11.50% |
Return on Assets (ROA) | 4.01% | 3.37% | 1.98% | 7.30% | 11.64% | 5.85% |
Return on Invested Capital (ROIC) | 10.13% | 9.40% | 5.92% | 22.94% | 37.17% | 18.17% |
Return on Capital Employed (ROCE) | 7.00% | 5.80% | 3.50% | 12.40% | 19.40% | 8.10% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 21, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 2.40% | 3.47% | 3.62% | 5.48% | 6.26% | 0.96% |
FCF Yield | -1.98% | 0.42% | 0.47% | 5.58% | 2.16% | -1.39% |
Dividend Yield | 0.93% | 1.43% | 1.47% | 1.58% | 1.26% | 0.19% |
Payout Ratio | 39.30% | 34.88% | 67.65% | 29.29% | 6.40% | 13.61% |
Buyback Yield / Dilution | 2.51% | -1.60% | 2.67% | 1.16% | -7.43% | -4.12% |
Total Shareholder Return | 3.44% | -0.16% | 4.14% | 2.74% | -6.17% | -3.93% |